EUVIMEDEUVIMED entdecken
Kommentar

Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States

Ken Zhao, Hooman Yarmohammadi

American Journal of Roentgenology · 10.11.2026 · 1-1

DOI: 10.2214/ajr.26.35001 ↗

Kurz gefasst

Kommentar in der Zeitschrift American Journal of Roentgenology, online erschienen am 10.11.2026. Verfasst von Ken Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA 10065.

Zitieren

APA

Zhao, K., & Yarmohammadi, H. (2026). Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States. American Journal of Roentgenology, 1-1. https://doi.org/10.2214/ajr.26.35001

Vancouver

Zhao K, Yarmohammadi H. Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States. American Journal of Roentgenology. 2026:1-1. doi:10.2214/ajr.26.35001

BibTeX
@article{Zhao2026,
  author = {Zhao, Ken and Yarmohammadi, Hooman},
  title = {Evidence Supporting the Shift Toward Radioembolization as the Primary Bridging Therapy for Liver Transplant Candidates With Hepatocellular Carcinoma in the United States},
  journal = {American Journal of Roentgenology},
  year = {2026},
  pages = {1--1},
  doi = {10.2214/ajr.26.35001}
}
Kostenlos starten →